Digital health technologies have the potential to revolutionize healthcare delivery and can be deployed to produce better health outcomes, improve patient experience, promote equity, and lower costs.
However, unlike other sectors where the introduction of automation and technology tends to reduce costs, technological advancements in healthcare have often led to increasing costs and only marginal improvements in quality. The last decade has witnessed a major boom in digital health technology investment, despite limited evidence about the clinical and economic impact of new apps, digital therapeutics, remote patient monitoring, and other technologies. Without a clear regulatory pathway or independent assessor, healthcare stakeholders struggle to make decisions regarding coverage, price, and investments for these technologies.
“Think of all these technologies – there’s a lot of missing evidence, no long-term studies, and a lot of poorly constructed cohort studies. We need evidence and a focused entity trying to keep up and evaluate what is missing, especially for [digital health technologies] with an important social mission.”
“When a [company] says certain outcomes will improve by 40%, what we need to know is where did the math come from? How good is underlying evidence for that?” – Self-Insured Employer”
Stay up to date
Sign up to receive updates.